Although its role is often
compared with that of NICE in the UK, HAS issues opinions, recommendations and advice that integrate directly
into a wider decision-making network through which new
technologies are introduced into the French healthcare system. Through the work of its internal committees—the
Transparency Commission (TC) for the appraisal of pharmaceutical products